baber/WOPTO huggingface dataset:
Patent NZ-331793-A (NZ)
Title: Organoamine siloxane alkoxylate surfactants and their use in pesticides
Inventor: POLICELLO GEORGE A
IPC: C09K23/54
Filed: 1997-03-06
Abstract: It has been discovered that organoamine modified siloxane alkoxylates overcome the antagonism associated with nonionic trisiloxane alkoxylates on pesticide uptake in plants. The organoamine modified siloxane alkoxylates of the application have the average general formula: AMe2SiO[(Me)2SiO]x[MeSi(Z)O]ySiMe2A, wherein x = 0 to 1, y = 0 to 2, with the proviso than when y = 0, A is Z, A is Z or Me, Z = RO(R1)nR2N(R3)2, R is a divalent organic group having from 2 to 4 carbon atoms, R1 is an alkyleneoxide group containing 2 to 4 carbon atoms, R2 is a divalent organic group containing 2 to 6 carbon atoms, R3 may be hydrogen, an alkyl radical with 1 to 4 carbons, an amino alkyl of one to four carbons, or an alkyl of 2 to 4 carbon atoms which may have hydroxy substitutions thereon and each R3 may be the same or different.
Patent NZ-334835-A (NZ)
Title: High heeled shoe with anatomically shaped arch
Inventor: DANANBERG HOWARD J
IPC: A43B7/22
Filed: 1997-09-30
Abstract: A shoe construction consists of a rigid molded device (116) comprising a heel cup (118) and an anatomically shaped arch appliance (120) extending forwardly from the heel cup to just proximal to the metatarsal heads. It is stated that this causes the foot of the wearer to assume an anatomically correct position in the shoe, provides torsional stability and contributes to shoe structure integrity.
Patent NZ-336637-A (NZ)
Title: Method for stocking and preserving green wood timber using a controlled environment low in oxygen
Inventor: MAHLER GEROLD
IPC: B27K5/00
Filed: 1997-12-19
Abstract: Provided is a method of preserving and storing green wood comprising: 1 Storing the wood inside an airtight and optionally light-tight cover, 2 Allowing an adjustment period after storage, during which the respiratory and fermentation processes of fungi and bacteria, and the respiratory processes of the still-living wood cells, consume oxygen and produce carbon dioxide, water and organic acids, of 3 to 10 days, and 3 Maintaining and monitoring the oxygen content in side the cover at less than 0.1 volume percent and the carbon dioxide content from 21 to 40 volume percent, throughout the entire storage period, thereby largely preventing the growth of wood destroying fungi. The initial adjustment period can be optionally shorten by first fumigating the wood with carbon dioxide.
Patent NZ-500058-A (NZ)
Title: Preparation of polycaprolactam
Inventor: FUCHS EBERHARD
IPC: C07D201/08
Filed: 1996-05-07
Abstract: The production of caprolactam by reacting 6-amino capronitrile with water in the presence of catalysts, using an initial mixture of 6-amino capronitrile and the tetrahydroazepine derivative of formula (I), and reaction in the liquid phase in the presence of heterogeneous catalysts, and a process for producing tetrahydroazepine derivative (I) and its use for making polycaprolactam.
Patent NZ-504814-A (NZ)
Title: Removable Z connector for electric fence
Inventor: DEAL GEOFFREY EDGAR WALTER
IPC: H01B17/16
Filed: 2000-05-30
Abstract: An electric fence connector comprising a conductive wire adapted at one end to form a zig zag shaped portion of a sufficient length, in use, to allow a first conductive element to be folded over and through the zig zag shaped portion and be secured to the wire.  The other end of the wire is adapted to be attachable to a second conductive element to allow, in use, electricity to flow between the first conductive element and the second conductive element through the conductive wire.
Patent NZ-505604-A (NZ)
Title: A post assembly
Inventor: BOXSELL DESMOND JAMES
IPC: E01F9/00
Filed: 2000-07-06
Abstract: A post assembly (10) comprising a base member (12), an arm assembly (11) pivotally mounted on said base member (12), locking means (15) for preventing selective pivotal movement of said arm assembly (11) relative to said base member (12), and a post (13) having a cavity formed in an end portion (14), which is adapted to receive the arm member (11) in a substantially upright operative condition.  The locking means (15) are configured to permit pivotal movement of the arm assembly (11) on application of a force in excess of the predetermined value.
Patent NZ-505796-A (NZ)
Title: A two wheel in-line skateboard
Inventor: ATTEY GRAEME SCOTT
IPC: A63C17/01
Filed: 1998-12-30
Abstract: An in-line skateboard (10) includes a longitudinally extending frame (18) located between aligned wheels (14, 16).  The frame (18) is pivotally connected at (32) to a leading wheel (14) by means of a fork member (30), which extends from an axle (15) of the wheel (14).  The pivotal connection (32) is disposed below the level of the axle (15).
Patent NZ-507200-A (NZ)
Title: Dosing regimens for lasofoxifene
Inventor: THOMPSON DAVID DUANE
IPC: A61K31/401
Filed: 2000-09-28
Abstract: Based on lasofoxifene's half-life and potency, the drug may be dosed once per week and achieve a similar effect as if given daily. Accordingly the invention relates to novel lasofoxifene compositions and their manufacture which achieves this effect.
Patent NZ-517582-A (NZ)
Title: Strapper with removable feed wheel cleaning device
Inventor: CHEUNG NELSON
IPC: B65B13/12
Filed: 2002-03-04
Abstract: Feed wheel 20 is carried on subassembly 4 and removable feed wheel cleaning element 24 is also on the subassembly.
Patent NZ-522481-A (NZ)
Title: (-)-5-(3-Chlorophenyl)-ec-(4-chlorophenyl)-oc-(1-methyl-lH-imidazol-5-yl)- tetrazolo [1,5-a] quinazoline-7-methanamine a farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer
Inventor: VENET MARC GASTON
IPC: A61K31/519
Filed: 2001-06-13
Abstract: Disclosed herein is a farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer such as (-)-5-(3-Chlorophenyl)-a-(4-chlorophenyl)-a-(1-methyl-1H-imidazol-5-yl)tetrazolo-[1,5-a]quinazoline-7-methanamine and its pharmaceutically acceptable acid addition salts, and the use of such compounds in medicine especially for the treatment of cancer.
Patent NZ-537324-A (NZ)
Title: Stable nanoparticulate fenofibrate formulations
Inventor: RYDE TUULA
IPC: A61K9/16
Filed: 2003-05-23
Abstract: Disclosed is a stable fenofibrate composition for oral administration comprising: (I) particles of fenofibrate having a D50 particle size of less than about 500 nm, and (II) at least one surface stabilizer, wherein: (i) the composition exhibits bioequivalence upon administration to a human subject in a fed state as compared to administration to a human subject in a fasted state; where bioequivalency is established by: (a) a 90% Confidence Interval for AUC which is between 80% and 125%,and (b) a 90% Confidence Interval for Cmax, which is between 80% and 125%; (ii) the composition redisperses in a biorelevant media; and (iii) the composition is phospholipid-free.
Patent NZ-538575-A (NZ)
Title: Method for the amplification of a virus wherein primary avian cells are cultivated in a serum-free medium comprising growth factors and attachment factors
Inventor: RATHE INGMAR
IPC: A61K39/275
Filed: 2003-09-01
Abstract: A method for the cultivation of primary cells is described. The primary cells are cultivated in a serum free medium comprising a factor selected from the group consisting of growth factors and attachment factors. The method for the cultivation of primary cells may be one step in a method for the amplification of viruses, such as poxviruses. The cells are then infected with the virus and the infected cells are cultivated in serum free medium until progeny virus is produced.
Patent NZ-539429-A (NZ)
Title: Heuristic method of classification
Inventor: HITT BEN
Filed: 2001-06-19
Abstract: A method of constructing a model to classify objects using a plurality of data strings, where each data string is associated with one of a plurality of objects to be classified, is disclosed. The methods includes the steps of (a) abstracting a set of selected data points from each data string, (b) grouping the set of data points, and (c) repeating the abstracting and grouping with another set of selected data points from each data string until a grouping is created that is acceptable as a model to classify the objects.
Patent NZ-539509-A (NZ)
Title: Priming vaccine comprising a polynucleotide encoding at least one first malarial antigen and a boosting vaccine comprising at least one polypeptide comprising at least one second malarial antigen having at least one epitope in common with the first malarial antigen of the priming vaccine
Inventor: HOFFMAN STEPHEN L
IPC: A61K/
Filed: 2003-10-22
Abstract: Disclosed are methods for protecting against malaria infection by vaccination. The method disclosed involves priming an anti-malaria immune response with a DNA-based vaccine and boosting that response with a protein-based vaccine. It also relates to broadening the resulting immune response by boosting with a protein-based vaccine.
Patent NZ-542496-A (NZ)
Title: Device for applying and heat-shrinking plastics labels, and process for applying said labels
Inventor: GHINI ENRICO
IPC: B65C3/06
Filed: 2004-02-20
Abstract: A device (1) for applying and heat-shrinking plastics labels comprising a central body (2) and an outer body (3), coaxially movable one within the other one by the action of an injector element (14), positioned in such a way to form an interspace (20) between the central and outer bodies, and shaped in such a way to receive a label (19) to be applied, and to position the same about the outer surface of a container (18). Means (16) for introducing hot air into the interspace are provided, to enable heat-shrinking of the label. Means (4) to bring the outer body (3) back in the rest position, after having stopped the action on the injector element, are also provided. A process for applying plastics labels is also described.
Patent NZ-544980-A (NZ)
Title: Entry inhibitors of the HIV virus
Inventor: VAN ACKER KOENRAAD LODEWIJK AUGUST
IPC: C07C235/16
Filed: 2004-09-10
Abstract: Disclosed is a compound of formula (I), or pharmaceutically acceptable salts thereof, wherein A represents isoquinolinyl, phenyl substituted with R1, or 1,2,3,4-tetrahydroquinolinyl substituted with -Y-X-R2, wherein Y represents -S(=O)2- or -C(=O)-, and wherein the rest of the subtituents are disclosed in the specification. Also disclosed is the suitability of the above compound for treating HIV, AIDS, AIDS-related complex (ARC), progressive generalized lymphadenopathy (PGL), HIV mediated dementia and HIV mediated multiple sclerosis.
Patent NZ-545295-A (NZ)
Title: Portable combination bedside co-sleeper
Inventor: MARTIN BRUCE
IPC: A47D7/04
Filed: 2003-11-25
Abstract: A portable combination bedside co-sleeper (10). The co-sleeper includes an enclosure (15) having an open top (20), a floor (25), a mattress support panel (30), a front wall (35), and at least one surrounding wall (40) connected to the front wall. The floor has a top surface (45), a bottom surface (50) and surrounding side edges (55) and being attached to the front wall and the surrounding wall at the surrounding side edges. The mattress support panel has an upper surface (60), a lower surface (65), an outer perimeter (70) and is removably attached to the front wall and the surrounding wall at the outer perimeter and being spaced upwardly from the floor. A mattress pad (75) has an upper surface (80), a lower surface (85) and is sized and shaped to fit slidably between the front wall and the surrounding wall. Means (90) are provided for reversibly lowering a height (95) of at least a portion (100) of the front wall, from a first position (105) at the top to at least one second position (110) below the top. A securing strap assembly (115) is provided for securing the co-sleeper to a parental bed (120). When the front wall is raised to the first position, the co-sleeper is usable as a bassinet; and when the front wall is then lowered to one of its second positions, the co-sleeper is usable as a changing table. When the securing strap assembly is properly positioned and the co-sleeper is secured to the parental bed it will serve as a co-sleeper. The mattress support panel is removably attached to the front wall and the surrounding wall at the outer perimeter using a first zipper (180).
Patent NZ-555303-A (NZ)
Title: 2,5 and 2,6-disubstituted benzazole analogues useful as protein kinase inhibitors
Inventor: HERZ THOMAS
IPC: C07D473/34
Filed: 2005-12-22
Abstract: Disclosed are benzoxazole and benzothiazole derivatives as represented by the general formula (I), wherein the substituent ûY-R1 is attached to the 5- or 6-position of the benzazole moiety; X independently represents S, O, SO, or SO--2; Y independently represents S, O, NR2, SO, or SO2; and the other substituents are as defined herein. Also disclosed is a composition containing a compound as defined above (which may additionally include an adjuvant and/or an additive). Further disclosed is the use of a compound as defined above for the preparation of a pharmaceutical composition for treating, relieving, and/or preventing cancer, or for the treatment of diseases which are cured or relieved by the inhibition of one or several kinases.
Patent NZ-560713-A (NZ)
Title: VEGF antagonist formulations
Inventor: DIX DANIEL
IPC: A61K38/17
Filed: 2006-03-22
Abstract: Provided is a stable liquid formulation of a vascular endothelial growth factor (VEGF)-specific fusion protein antagonist, comprising 10-50 mg/ml of a fusion protein having a receptor component consisting of an immunoglobulin-like (Ig) domain 2 of a first VEGF receptor and Ig domain 3 of a second VEGF receptor, wherein the first VEGF receptor is FltI and the second VEGF receptor is FlkI or Flt4, and a multimerizing component, a buffer, 25-150 mM NaCl, 5-30% sucrose, 0.05-0.10% polysorbate, at a pH of about 6- 6.5, wherein at least about 92 percent of the fusion protein maintains its native conformation after 12 months of storage at 5°C. The composition can be also in (pre)lyophilized form.
Patent NZ-564047-A (NZ)
Title: Mixing apparatus
Inventor: MUNRO HERBERT JOHN
IPC: B67D7/08
Filed: 2007-12-03
Abstract: A foam delivery system 50 for delivery of foam insulation into a cavity including a fluid controller 1 configured to receive a plurality of fluids 51 52 53, at least two of which are liquids, the fluid controller 1 including at least one test parameter transducer configured to measure a test parameter for each fluid, and a mixing chamber configured to receive a plurality of fluids from the fluid controller and to mix the fluids to form a foam for installation into the cavity, wherein the fluid controller 1 is configured to stop delivery of all fluids to the mixing chamber if the measured test parameter of any fluid falls outside of a preset allowed range of values for that fluid, characterised in that the test parameter transducer for each liquid is configured to measure the temperature of that liquid.
Patent NZ-567873-A (NZ)
Title: Dry powder composition for examining drug solubility which comprises a complex prepared only from a bile salt and a phospholipid
Inventor: LEIGH STEVE
IPC: A61K47/28
Filed: 2006-11-10
Abstract: Disclosed is a solid dissolution composition in the form of a powder (which typically contains less than 5% by weight water), for preparing a biorelevant media to evaluate the solubility and dissolution characteristics of poorly water soluble compounds and formulations; said powder comprises a complex which consists of (a) at least one bile salt (such as sodium cholate, sodium taurocholate, sodium glycocholate, sodium deoxycholate, sodium taurodeoxycholate, sodium glycodeoxycholate, sodium ursodeoxycholate, sodium chenodeoxycholate, sodium taurochenodeoxycholate, sodium glycochenodeoxycholate, sodium cholylsarcosinate or sodium N-methyl taurocholate), and (b) at least one phospholipid, selected from the group consisting of natural lecithins, enzyme hydrolysed lecithin, monoacylphospholipids, and mixtures of at least one diacylphospholipid and at least one monoacylphospholipid, with (c) a mole ratio of the bile salt to the phospholipid between 20:1 and 1:1 and (d) optionally one or more other lipids selected from the group consisting of fatty acids, cholesterol, monoglycerides, diglycerides, and triglycerides.
Patent NZ-574042-A (NZ)
Title: Insertion instrument comprising elongated shaft, a suction head, a suction duct and guiding track
Inventor: KELLER ARNOLD
IPC: A61F2/46
Filed: 2007-06-26
Abstract: An insertion instrument for joint sockets of prosthesis that uses vacuum suction is disclosed. The instrument comprises an elongated shaft (1), a suction head (2) provided at front end for connection to the joint socket, a suction device with a piston guided in the shaft (1), a suction duct which merges into the suction head and an actuating element which is guided along a guide track (14). The guiding track (14) is helically formed and comprises a locking device, in the form of recess (15) for the actuating element in a suction position. Due to the helical form of the guiding track (14), the actuating element executes a rotational and longitudinal movement during its displacement. The longitudinal movement produces a negative pressure in the suction duct, thereby ensuring the maintenance of said pressure, while the rotating movement causes the rotation of the actuating element to an extent that it reaches its locking position at the end of the guiding track (14).
Patent NZ-574812-A (NZ)
Title: Polymeric low-tack ophthalmic and otorhinolaryngological device materials suited for use as intraocular lens materials
Inventor: CORDOVA DIANA M
IPC: A61F2/16
Filed: 2007-07-20
Abstract: Disclosed is a polymeric low-tack acrylic opthalamic and otorhinolaryngological device material comprising: 1. a principle device forming monomer which is an aryl acrylic hydrophobic monomer of formula (I); 2. a dimethylacryloxypropyl-terminated polydimethylsiloxane macromer of formula (II); 3. and a cross linking monomer, wherein all substituents are as defined in the specification. Also defined is a device comprising the device material wherein the device is selected from the group consisting of a contact lens; a keratoprostheis, a corneal inlay or ring; an otological ventilation tube; and a nasal implant.
Patent NZ-576526-A (NZ)
Title: Identifying and tracking users in network communications
Inventor: JOE PHILLIP
IPC: G06F21/00
Filed: 2010-04-23
Abstract: A method of monitoring access to a communications network through a local access network configured for use by a plurality of users and/or client devices in one or more sessions and a local network access module are disclosed. The module comprises means for assigning or receiving a unique network identifier for a client device and/or session and/or user of a local access network; and means for storing and/or transmitting session data corresponding to the unique network identifier in association with the unique network identifier and/or in association with a user of the client device and/or in association with the client device such that identification of the user and/or the client device can be established for that session to therefore enable monitoring and tracking usage for that client device or user. Also disclosed is a system for monitoring access to a communications network through a local access network configured for use by a plurality of users and/or client devices including the above described module.
Patent NZ-576926-A (NZ)
Title: Method and process plant for liquefaction of gas
Inventor: BRENDENG EINAR
IPC: F25J1/02
Filed: 2007-11-01
Abstract: Disclosed is a method for cooling and optionally liquefaction of a product gas, based on a closed loop of multi-component refrigerant with a joined composition of a more volatile fraction and a less volatile fraction, in heat exchange with the gas to be cooled and optionally condensed, the method comprising the steps of: a) directing the product gas to be cooled through at least one primary two-flow heat exchanger, b) directing the refrigerant with the joined composition from a first of at least two secondary two-flow heat exchangers through at least one compressor, c) removing heat absorbed by the refrigerant by heat exchange in one or more heat exchangers, d) passing the cooled refrigerant into at least one phase-separator for separating the refrigerant into the more volatile fraction and the less volatile fraction, e) cooling the more volatile fraction in heat exchange with low pressure refrigerant of the joined composition by passing it through the first of the at least two secondary heat exchangers, f) further cooling the more volatile fraction in heat exchange through the second of at least two secondary two-flow heat exchangers, g) directing a first part of the further cooled more volatile fraction from the second of at least two secondary heat exchangers to a first throttling device and directing this part into heat exchange in the second of at least two secondary heat exchangers as a first low pressure refrigerant, h) directing the remaining other part of the further cooled more volatile fraction from the second of the at least two secondary heat exchangers to a second throttling device to become a remaining low pressure refrigerant and directing this part into heat exchange with the product gas to be cooled through at least one primary heat exchanger, i) throttling by means of a third throttling device the less volatile fraction from the at least one phase-separator to become a second low pressure refrigerant and directing this less volatile fraction, combined with the remaining low pressure refrigerant from the at least one primary heat exchanger and the first low pressure refrigerant from the second of at least two secondary heat exchangers, wherein the second low pressure refrigerant with a less volatile fraction, the first low pressure refrigerant with the first part of the more volatile fraction and the remaining low pressure refrigerant with the remaining other part of the more volatile fraction forms the total amount of the joined composition, low pressure refrigerant, into heat exchange and complete vaporization through the first of the at least two secondary heat exchangers, and j) closing the loop by directing the vaporized refrigerant to the compressor. A process plant for cooling and optionally liquefaction of a product gas is also disclosed.
Patent NZ-578477-A (NZ)
Title: A bag of heat-shrinkable gas-barrier thermoplastic film
Inventor: SMITH ADRIAN MAXWELL WILLIAM
IPC: B65D30/02
Filed: 2009-07-17
Abstract: A bag 10 of a heat shrinkable, gas-barrier thermoplastic film for packaging at least one item, the bag 10 comprising a) a bottom edge 12, b) first and second side edges 14 16, c) an open mouth 18, d) a first seal 20 disposed adjacent the bottom edge 12 and connecting the first and second side edges 14 16, the first seal 20 defining an area between it, the first and second side edges 14 16 and the open mouth 18 for receiving the at least one item to be packaged, e) a second seal 24 disposed substantially along the bottom edge 12 or between the bottom edge 12 and the first seal 20 and connecting the first and second side edges 14 16, the second seal having a shaped portion adjacent a corner of the bag 10 defined by one of the first and second side edges 14 16 and the bottom edge 12 which projects towards the open mouth 18, the shaped portion having an apex 30 closest to the open mouth 18, f) a pre-cut 34 formed in the thermoplastic film and extending from the bottom edge 12 towards the apex 30 of the shaped portion of the second seal, wherein the first seal 20 extends from the other of the first and second side edges 14 16 across the bag 10 towards the shaped portion of the second seal 24 at a spacing from the bottom edge 12 less than the spacing of the apex 30 from the bottom edge 12 and around the shaped portion of the second seal 24 to the one of the first and second side edges 14 16, and wherein a manually graspable tab 32 is formed in an area of the thermoplastic film delimited by the one of the first and second side edges 14 16, the first and second seals 20 24 adjacent the one of the first and second side edges 14 16 and the shaped portion of the second seal 24.